On July 18 Fresenius Kabi announced that they are rolling out a line of generic contrast media products, starting immediately with Iodixanol Injection USP. 

Radiologists are receiving salary offers averaging $455,000 to start a new job in 2022, up from $401,000 in 2021.  

A healthcare AI startup in Silicon Valley is partnering with a top-tier medical school—and hopefully a few good radiologists—to test a hypothesis that’s increasingly crucial to radiology.

Citing low health literacy as a barrier between providers and patients in overcoming healthcare disparities, DenseBreast-info.org updated their breast density materials to include more patient-friendly, “simple language.”

Per Bayer’s communications, the contrast agent is manufactured at the same site in Berlin, Germany as the Ultravist that is intended for U.S. markets, but due to its intended distribution abroad it lacks current FDA-approved labeling. 

A retrospective analysis of cross-sectional venograms shows only 4.5% of a teaching hospital’s COVID-vaccinated patients had a clotting condition in early 2021. Meanwhile the rate for the unvaccinated was 10.1%.

A machine learning system for planning spine surgery that also predicts post-op spinal alignment six months out has cleared the FDA’s 510(k) review process.

When counseling patients with architectural distortion on digital breast tomosynthesis (DBT) but no signs of malignancy on biopsy, mammographers should raise imaging alone as a sound option for surveillance.